Delivery Order SPE2DB20D3103-SPE2DB24FP2G6
Award Date
6/18/24
Potential Completion Date
7/11/24
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 120 tablets of the medication NUBEQA 300 MG. The $7,641.98 firm fixed-price contract has an ultimate completion date of July 22, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to supply a wide range of pharmaceutical products and medical supplies in...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 120 tablets of the prescription medication NUBEQA 300 MG. The $7,641.98 firm fixed-price delivery order does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of July 22, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $7,641.98 firm fixed-price delivery order is for the supply of NUBEQA 300 MG TABLET 120S, a prescription medication. The contract has an ultimate completion date of June 18, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,641.98 firm fixed-price delivery order is for the supply of 120 tablets of the medication NUBEQA 300 MG. The contract has an ultimate completion date of July 14, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,518.40 firm fixed-price delivery order is for the supply of NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract has a period of performance through March 21, 2024. This delivery order appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $7,641.98 for the supply of NUBEQA 300 MG TABLET 120S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 31, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,641.98 firm fixed-price delivery order is for the drug NUBEQA 300 MG TABLET 120S and has an ultimate completion date of March 28, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for the delivery of NUBEQA 300 MG Tablets. The $4,683.97 firm fixed price contract has a ceiling value and an ultimate completion date of September 3, 2024. This award is not associated with a set-aside program. As a key supplier of medical commodities to the U.S. federal government, Amerisourcebergen leverages its extensive distribution network to provide a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The $7,280.00 firm fixed price delivery order is for the supply of 120 tablets of the drug NUBEQA 300 MG. The contract has an ultimate completion date of June 30, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
The U.S. Defense Logistics Agency (DLA) awarded a $9,367.94 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office Division for the supply of 120 tablets of the pharmaceutical product NUBEQA 300 mg. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support...